{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:07:06Z","timestamp":1776899226578,"version":"3.51.2"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-024-03063-3","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T08:32:07Z","timestamp":1710318727000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Subthreshold laser compared to oral spironolactone for the treatment of chronic central serous chorioretinopathy: a retrospective study"],"prefix":"10.1007","volume":"44","author":[{"given":"Stefano","family":"Mercuri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco Maria","family":"D\u2019Alterio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walid","family":"Raslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Khairat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Corazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad","family":"Younis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,13]]},"reference":[{"key":"3063_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2015.05.003","author":"A Daruich","year":"2015","unstructured":"Daruich A, Matet A, Dirani A et al (2015) Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.05.003","journal-title":"Prog Retin Eye Res"},{"key":"3063_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.02.016","author":"S Gattoussi","year":"2017","unstructured":"Gattoussi S, Freund KB (2017) Multimodal imaging in central serous chorioretinopathy. Ophthalmology. https:\/\/doi.org\/10.1016\/j.ophtha.2017.02.016","journal-title":"Ophthalmology"},{"key":"3063_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2012.07.004","author":"B Nicholson","year":"2013","unstructured":"Nicholson B, Noble J, Forooghian F, Meyerle C (2013) Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol. https:\/\/doi.org\/10.1016\/j.survophthal.2012.07.004","journal-title":"Surv Ophthalmol"},{"key":"3063_CR4","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5000796","author":"J Ruiz-Medrano","year":"2017","unstructured":"Ruiz-Medrano J, Pellegrini M, Cereda MG, Cigada M, Staurenghi G (2017) Choroidal characteristics of acute and chronic central serous chorioretinopathy using enhanced depth imaging optical coherence tomography. Eur J Ophthalmol. https:\/\/doi.org\/10.5301\/ejo.5000796","journal-title":"Eur J Ophthalmol"},{"key":"3063_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.11.017","author":"LA Yannuzzi","year":"2010","unstructured":"Yannuzzi LA (2010) Central serous chorioretinopathy: a personal perspective. Am J Ophthalmol. https:\/\/doi.org\/10.1016\/j.ajo.2009.11.017","journal-title":"Am J Ophthalmol"},{"key":"3063_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3182680a66","author":"AT Fung","year":"2012","unstructured":"Fung AT, Yannuzzi LA, Bailey FK (2012) Type 1 (Sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina. https:\/\/doi.org\/10.1097\/IAE.0b013e3182680a66","journal-title":"Retina"},{"issue":"9","key":"3063_CR7","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1055\/s-0032-1315077","volume":"229","author":"W Inhoffen","year":"2012","unstructured":"Inhoffen W, Ziemssen F, Bartz-Schmidt KU (2012) Chronic central serous chorioretinopathy (cCSC): differential diagnosis to choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD). Klin Monatsbl Augenheilkd 229(9):889\u2013896. https:\/\/doi.org\/10.1055\/s-0032-1315077","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"3063_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000331","author":"CE Pang","year":"2015","unstructured":"Pang CE, Freund KB (2015) Pachychoroid neovasculopathy. Retina. https:\/\/doi.org\/10.1097\/IAE.0000000000000331","journal-title":"Retina"},{"key":"3063_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.07.003","volume":"73","author":"TJ van Rijssen","year":"2019","unstructured":"van Rijssen TJ, van Dijk EHC, Yzer S, Ohno-Matsui K, Keunen JEE, Schlingemann RO, Sivaprasad S, Querques G, Downes SM, Fauser S, Hoyng CB, Piccolino FC, Chhablani JK, Lai TYY, Lotery AJ, Larsen M, Holz FG, Freund KB, Yannuzzi LA, Boon CJF (2019) Central serous chorioretinopathy: towards an evidence-based treatment guideline. Prog Retin Eye Res 73:100770. https:\/\/doi.org\/10.1016\/j.preteyeres.2019.07.003. (Epub 2019 Jul 15 PMID: 31319157)","journal-title":"Prog Retin Eye Res"},{"issue":"7","key":"3063_CR10","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/eye.2016.79","volume":"30","author":"A Ozkaya","year":"2016","unstructured":"Ozkaya A, Alkin Z, Ozveren M, Yazici AT, Taskapili M (2016) The time of resolution and the rate of recurrence in acute central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy: a case\u2013control study. Eye 30(7):1005\u20131010. https:\/\/doi.org\/10.1038\/eye.2016.79","journal-title":"Eye"},{"key":"3063_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2005.01027.x","author":"NV Baran","year":"2005","unstructured":"Baran NV, G\u00fcrl\u00fc VP, Esgin H (2005) Long-term macular function in eyes with central serous chorioretinopathy. Clin Exp Ophthalmol. https:\/\/doi.org\/10.1111\/j.1442-9071.2005.01027.x","journal-title":"Clin Exp Ophthalmol"},{"key":"3063_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200006000-00009","author":"TH Maaranen","year":"2000","unstructured":"Maaranen TH, Tuppurainen KT, M\u00e4ntyj\u00e4rvi MI (2000) Color vision defects after central serous chorioretinopathy. Retina. https:\/\/doi.org\/10.1097\/00006982-200006000-00009","journal-title":"Retina"},{"key":"3063_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200202000-00004","author":"RH Loo","year":"2002","unstructured":"Loo RH, Scott IU, Flynn HW et al (2002) Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina. https:\/\/doi.org\/10.1097\/00006982-200202000-00004","journal-title":"Retina"},{"key":"3063_CR14","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S115685","author":"MB Breukink","year":"2017","unstructured":"Breukink MB, Dingemans AJM, Den Hollander AI et al (2017) Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life. Clin Ophthalmol. https:\/\/doi.org\/10.2147\/OPTH.S115685","journal-title":"Clin Ophthalmol"},{"key":"3063_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)01438-1","author":"MSM Wang","year":"2002","unstructured":"Wang MSM, Sander B, Larsen M (2002) Retinal atrophy in idiopathic central serous chorioretinopathy. Am J Ophthalmol. https:\/\/doi.org\/10.1016\/S0002-9394(02)01438-1","journal-title":"Am J Ophthalmol"},{"key":"3063_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-4-15","author":"L Verma","year":"2004","unstructured":"Verma L, Sinha R, Venkatesh P, Tewari HK (2004) Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: a pilot, randomized controlled trial [ISRCTN84128484]. BMC Ophthalmol. https:\/\/doi.org\/10.1186\/1471-2415-4-15","journal-title":"BMC Ophthalmol"},{"key":"3063_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.08.026","author":"SN Chen","year":"2008","unstructured":"Chen SN, Hwang JF, Tseng LF, Lin CJ (2008) Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage. Ophthalmology. https:\/\/doi.org\/10.1016\/j.ophtha.2008.08.026","journal-title":"Ophthalmology"},{"issue":"6","key":"3063_CR18","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1177\/112067210801800613","volume":"18","author":"P Lanzetta","year":"2008","unstructured":"Lanzetta P, Furlan F, Morgante L, Veritti D, Bandello F (2008) Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy: a pilot study. European J Ophthalmology 18(6):934\u2013940","journal-title":"European J Ophthalmology"},{"key":"3063_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2009.02157.x","author":"B Gupta","year":"2009","unstructured":"Gupta B, Elagouz M, McHugh D, Chong V, Sivaprasad S (2009) Micropulse diode laser photocoagulation for central serous chorio-retinopathy. Clin Exp Ophthalmol. https:\/\/doi.org\/10.1111\/j.1442-9071.2009.02157.x","journal-title":"Clin Exp Ophthalmol"},{"issue":"3","key":"3063_CR20","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1177\/1120672120915169","volume":"31","author":"MC Donati","year":"2021","unstructured":"Donati MC, Murro V, Mucciolo DP, Giorgio D, Cinotti G, Virgili G, Rizzo S (2021) Subthreshold yellow micropulse laser for treatment of diabetic macular edema: comparison between fixed and variable treatment regimen. Eur J Ophthalmol 31(3):1254\u20131260. https:\/\/doi.org\/10.1177\/1120672120915169","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"3063_CR21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3928\/23258160-20130909-08","volume":"44","author":"L Roisman","year":"2013","unstructured":"Roisman L, Magalh\u00e3es FP, Lavinsky D, Moraes N, Hirai FE, Cardillo JA, Farah ME (2013) Micropulse diode laser treatment for chronic central serous chorioretinopathy: a randomized pilot trial. Ophthalmic Surg, Lasers Imaging Retina 44(5):465\u2013470. https:\/\/doi.org\/10.3928\/23258160-20130909-08","journal-title":"Ophthalmic Surg, Lasers Imaging Retina"},{"issue":"5","key":"3063_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41433-018-0309-7","volume":"33","author":"YJ Kim","year":"2019","unstructured":"Kim YJ, Kim SY, Ha S, Moon D, Seong S, Kwon OW, Park HS (2019) Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years. Eye 33(5):819\u2013825","journal-title":"Eye"},{"key":"3063_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318297a07a","author":"E Bousquet","year":"2013","unstructured":"Bousquet E, Beydoun T, Zhao M, Hassan L, Offret O, Behar-Cohen F (2013) Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study. Retina. https:\/\/doi.org\/10.1097\/IAE.0b013e318297a07a","journal-title":"Retina"},{"key":"3063_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12392","author":"MB Breukink","year":"2014","unstructured":"Breukink MB, den Hollander AI, Keunen JEE, Boon CJF, Hoyng CB (2014) The use of eplerenone in therapy-resistant chronic central serous chorioretinopathy. Acta Ophthalmol. https:\/\/doi.org\/10.1111\/aos.12392","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"3063_CR25","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1177\/1120672120952648","volume":"31","author":"D Fraenkel","year":"2021","unstructured":"Fraenkel D, Suffo S, Langenbucher A, Seitz B, Abdin AD (2021) Eplerenone for treatment of chronic central serous chorioretinopathy. Eur J Ophthalmol 31(4):1885\u20131891. https:\/\/doi.org\/10.1177\/1120672120952648","journal-title":"Eur J Ophthalmol"},{"key":"3063_CR26","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.5.2.2","author":"A Daruich","year":"2016","unstructured":"Daruich A, Matet A, Dirani A et al (2016) Oral mineralocorticoid-receptor antagonists: real-life experience in clinical subtypes of nonresolving central serous chorioretinopathy with chronic epitheliopathy. Transl Vis Sci Technol. https:\/\/doi.org\/10.1167\/tvst.5.2.2","journal-title":"Transl Vis Sci Technol"},{"issue":"9","key":"3063_CR27","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41433-019-0692-8","volume":"34","author":"Z Sun","year":"2020","unstructured":"Sun Z, Huang Y, Nie C, Wang Z, Pei J, Lin B, Zhou R, Zhang J, Chong V, Liu X (2020) Efficacy and safety of subthreshold micropulse laser compared with threshold conventional laser in central serous chorioretinopathy. Eye (Lond) 34(9):1592\u20131599","journal-title":"Eye (Lond)"},{"issue":"12","key":"3063_CR28","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1097\/IAE.0000000000000614","volume":"35","author":"E Bousquet","year":"2015","unstructured":"Bousquet E, Beydoun T, Rothschild PR, Bergin C, Zhao M, Batista R, Behar-Cohen F (2015) Spironolactone for nonresolving central serous chorioretinopathy: a randomized controlled crossover study. Retina 35(12):2505\u20132515","journal-title":"Retina"},{"key":"3063_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.04.021","author":"EHC van Dijk","year":"2018","unstructured":"van Dijk EHC, Fauser S, Breukink MB et al (2018) Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the place trial. Ophthalmology. https:\/\/doi.org\/10.1016\/j.ophtha.2018.04.021","journal-title":"Ophthalmology"},{"issue":"8","key":"3063_CR30","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1136\/bjophthalmol-2018-312892","volume":"103","author":"M Zola","year":"2019","unstructured":"Zola M, Daruich A, Matet A, Mantel I, Behar-Cohen F (2019) Two-year follow-up of mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy. British J Ophthalmol 103(8):1184\u20131189","journal-title":"British J Ophthalmol"},{"key":"3063_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-017-3783-x","author":"M Gaw\u0119cki","year":"2017","unstructured":"Gaw\u0119cki M, Jaszczuk-Maciejewska A, Jurska-Ja\u015bko A, Grzybowski A (2017) Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser. Graefe\u2019s Arch Clin Exp Ophthalmol. https:\/\/doi.org\/10.1007\/s00417-017-3783-x","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"3063_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2019-314047","author":"DS Petkovsek","year":"2019","unstructured":"Petkovsek DS, Cherfan DG, Conti FF et al (2019) Eplerenone for the treatment of chronic central serous chorioretinopathy: 3-year clinical experience. Br J Ophthalmol. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-314047","journal-title":"Br J Ophthalmol"},{"key":"3063_CR33","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0140-6736(19)32981-2","volume":"395","author":"A Lotery","year":"2020","unstructured":"Lotery A, Sivaprasad S, O\u2019Connell A et al (2020) Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial. Lancet 395:294\u2013303","journal-title":"Lancet"},{"key":"3063_CR34","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s10792-016-0377-2","volume":"37","author":"F Pichi","year":"2017","unstructured":"Pichi F, Carrai P, Ciardella A et al (2017) Comparison of two mineralcorticosteroids receptor antagonists for the treatment of central serous chorioretinopathy. Int Ophthalmol 37:1115\u20131125. https:\/\/doi.org\/10.1007\/s10792-016-0377-2","journal-title":"Int Ophthalmol"},{"key":"3063_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.12.1453","author":"WM Chan","year":"2003","unstructured":"Chan WM, Lam DSC, Lai TYY, Tam BSM, Liu DTL, Chan CKM (2003) Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol. https:\/\/doi.org\/10.1136\/bjo.87.12.1453","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"3063_CR36","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/00006982-200312000-00002","volume":"23","author":"FC Piccolino","year":"2003","unstructured":"Piccolino FC, Eandi CM, Ventre L, de la Longrais RCR, Grignolo FM (2003) Photodynamic therapy for chronic central serous chorioretinopathy. Retina 23(6):752\u2013763","journal-title":"Retina"},{"issue":"7","key":"3063_CR37","doi-asserted-by":"publisher","first-page":"e1522","DOI":"10.1111\/aos.15148","volume":"100","author":"MJ Sirks","year":"2022","unstructured":"Sirks MJ, van Dijk EHC, Rosenberg N, Hollak CEM, Aslanis S, Cheung CMG, Chowers I, Eandi CM, Freund KB, Holz FG, Kaiser PK, Lotery AJ, Ohno-Matsui K, Querques G, Subhi Y, Tadayoni R, Wykoff CC, Zur D, Diederen RMH, Boon CJF, Schlingemann RO (2022) Clinical impact of the worldwide shortage of verteporfin (Visudyne\u00ae) on ophthalmic care. Acta Ophthalmol 100(7):e1522\u2013e1532","journal-title":"Acta Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03063-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03063-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03063-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:47:05Z","timestamp":1741880825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03063-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,13]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3063"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03063-3","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,13]]},"assertion":[{"value":"26 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Authors have no financial\/conflicting interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"131"}}